-
Something wrong with this record ?
Terapeutika amyloidóz
[Therapeutics against amyloidosis]
Monika Holubová, Martin Hrubý
Chemické listy.
2016 ;
110 (12) :
851-859.
Language Czech Country Czech Republic
Document type Research Support, Non-U.S. Gov't, Review
Persistent link
https://www.medvik.cz/link/bmc17016782
- MeSH
- Amyloid MeSH
- Amyloidosis etiology drug therapy classification MeSH
- Azathioprine therapeutic use MeSH
- Chlorambucil therapeutic use MeSH
- Cholinesterase Inhibitors * administration & dosage pharmacology therapeutic use MeSH
- Galantamine administration & dosage pharmacology therapeutic use MeSH
- Immunotherapy methods MeSH
- Humans MeSH
- Melphalan therapeutic use MeSH
- Memantine therapeutic use MeSH
- Molecular Chaperones antagonists & inhibitors therapeutic use MeSH
- Rivastigmine administration & dosage pharmacology therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
The first part of this review deals briefly with the concept of amyloid, which is associated with the group of diseases called amyloidoses. The second section brings a brief overview of current clinically used therapeutics for selected types of amyloidoses. In the last section, examples are described of new experimental therapies of amyloidoses, which are currently under investigation.
Therapeutics against amyloidosis
Bibliography, etc.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17016782
- 003
- CZ-PrNML
- 005
- 20170619094556.0
- 007
- ta
- 008
- 170516s2016 xr a f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Holubová, Monika $7 xx0233049 $u Ústav makromolekulární chemie, v.v.i., Akademie věd České republiky, Praha
- 245 10
- $a Terapeutika amyloidóz / $c Monika Holubová, Martin Hrubý
- 246 31
- $a Therapeutics against amyloidosis
- 504 __
- $a Literatura
- 520 9_
- $a The first part of this review deals briefly with the concept of amyloid, which is associated with the group of diseases called amyloidoses. The second section brings a brief overview of current clinically used therapeutics for selected types of amyloidoses. In the last section, examples are described of new experimental therapies of amyloidoses, which are currently under investigation.
- 650 _2
- $a lidé $7 D006801
- 650 22
- $a amyloidóza $x etiologie $x farmakoterapie $x klasifikace $7 D000686
- 650 _2
- $a melfalan $x terapeutické užití $7 D008558
- 650 _2
- $a chlorambucil $x terapeutické užití $7 D002699
- 650 _2
- $a azathioprin $x terapeutické užití $7 D001379
- 650 _2
- $a amyloid $7 D000682
- 650 12
- $a cholinesterasové inhibitory $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D002800
- 650 _2
- $a memantin $x terapeutické užití $7 D008559
- 650 _2
- $a rivastigmin $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D000068836
- 650 _2
- $a galantamin $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D005702
- 650 _2
- $a imunoterapie $x metody $7 D007167
- 650 _2
- $a molekulární chaperony $x antagonisté a inhibitory $x terapeutické užití $7 D018832
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Hrubý, Martin, $d 1978 prosinec 15.- $7 xx0060770 $u Ústav makromolekulární chemie, v.v.i., Akademie věd České republiky, Praha
- 773 0_
- $t Chemické listy $x 0009-2770 $g Roč. 110, č. 12 (2016), s. 851-859 $w MED00011010
- 856 41
- $u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/119/119 $y domovská stránka časopisu
- 910 __
- $a ABA008 $b B 1918 $c 395 $y 4 $z 0
- 990 __
- $a 20170516142246 $b ABA008
- 991 __
- $a 20170619095014 $b ABA008
- 999 __
- $a ok $b bmc $g 1205216 $s 977591
- BAS __
- $a 3
- BMC __
- $a 2016 $b 110 $c 12 $d 851-859 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
- LZP __
- $c NLK109 $d 20170619 $a NLK 2017-18/dk
